Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

May 16, 2022 03:30 ET
Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program
Celmatix Inc. a biotechnology company focused on ovarian biology, today announced the identification of a novel AMHR2 agonist compound that has demonstrated robust biological activity in multiple therapeutically relevant preclinical assays and a pharmacokinetic profile consistent with the desired product profile for an injectable drug. The program, which was a product of Celmatix’s decade-long focus on identifying novel biomarkers and drug targets for women’s health, has a planned first clinical indication in the prevention of premature menopause in women undergoing chemotherapy. Loss of ovari...
May 16, 2022 03:13 ET
dynaCERT Invited to Present at the International Investment Forum (IIF)
dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that dynaCERT will be presenting at the third International Investment Form (“IIF”) on May 19th, 2022....
May 16, 2022 03:07 ET
Sysdig Introduces Sysdig Advisor to Drastically Simplify Kubernetes Troubleshooting
(KubeCon + CloudNativeCon Europe) -- Sysdig, the unified container and cloud security leader, announced the availability of Sysdig Advisor, a Kubernetes troubleshooting feature that consolidates and prioritizes relevant performance details in Sysdig Monitor. By providing a single view of performance and event information, Sysdig Advisor...
May 16, 2022 03:05 ET
Sysdig Welcomes Google Open Source Lead to Head up OSS Ecosystem Team
(KubeCon + CloudNativeCon Europe) — Sysdig, the unified container and cloud security leader, announced today that Edd Wilder-James has joined Sysdig from Google to lead the company’s open source ecosystem team. As VP of Open Source Ecosystem, Edd will expand the open source team at Sysdig, with a focus on community outreach and p...
May 16, 2022 03:04 ET
Sysdig Open Source Is Extended to Secure Cloud Services
(KubeCon + CloudNativeCon Europe) — Sysdig, the unified container and cloud security leader, announced that Sysdig open source, the incident response standard for containers, has been extended to the cloud. Using system calls, Sysdig open source (Sysdig OSS) traditionally offers deep observability into running applications, as well as file system access and network activity, which speeds incident response and troubleshooting. Teams can quickly filter information from Sysdig OSS and take action. With the announcement of this new integration, these capabilities have been extended beyond containe...
May 16, 2022 03:00 ET
GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE
GrAI Matter Labs, a pioneer of brain-inspired ultra-low latency computing, announced today that it will be unveiling GrAI VIP, a full-stack AI system-on-chip platform, to partners and customers at GLOBAL INDUSTRIE, May 17th-20th, 2022....
May 16, 2022 03:00 ET
H.I.G. Capital Expands European Middle Market LBO Team with the Addition of Stephan Madsen
H.I.G. Capital (“H.I.G.”), a leading global alternative asset investment firm with over $49 billion of equity capital under management, announced today that Stephan Madsen has joined the firm’s European Middle Market LBO team in London as a Managing Director focused on the Nordic region....
May 16, 2022 02:50 ET
U.S. Government Awards TROJAN Contract to SES Government Solutions
SES Government Solutions (SES GS), a wholly-owned subsidiary of SES, has been awarded a U.S. government TROJAN follow-on contract to support U.S. Army Intelligence and Security Command (INSCOM) for up to a five-year period. Using SES’s global network of satellite services, SES GS will continue to support the Army’s premier intelligence network in delivering operational intelligence capabilities and enhancing combat readiness....
May 16, 2022 02:00 ET
Atamyo Therapeutics Announces Significant Milestones for ATA-100 and ATA-200, its Gene Therapy Programs to Treat Limb-Girdle Muscular Dystrophy 2I/R9 and 2C/R5
Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, today announced multiple major milestones for ATA-100 and ATA-200, its one-time gene-replacement therapies for the treatment of limb-girdle muscular dystrophy types 2I/R9 and 2C/R5 (LGMD2I/R9 and LGMD2C/R5 respectiv...
May 16, 2022 02:00 ET
Pablo Isla Joins General Atlantic as Global Senior Advisor
General Atlantic, a leading global growth equity firm, announced today that Pablo Isla has joined the firm as a Global Senior Advisor. Based in Europe, Mr. Isla will provide strategic support and counsel to General Atlantic’s global Consumer and Technology investment teams and portfolio companies, with a focus on digital enablement....
May 16, 2022 01:30 ET
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat-Dx Rise – a high-capacity version of the QIAstat-Dx automated syndromic system – and enhancements to the menu of tests for the fully integrated one-step molecular testing solution that provides results in about one hour....
May 16, 2022 01:00 ET
Element Nutritional Sciences to Report Record Revenue in Q1 2022
Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased to provide an update highlighting preliminary financial results for the first quarter ended March 31, 2022 (“Q1 2022”) and recent operational milestones. All amounts are expressed in Canadian dollars....
May 16, 2022 01:00 ET
LG Chem Develops Advanced Plastic Product to Prevent Thermal Runaway in EV Batteries
LG Chem (KRX: 051910) today announced that it has developed a new plastic product for battery application that is capable of preventing the spread of flame in batteries, delivering the longest fire-resistance performance in the world....
May 16, 2022 00:01 ET
All-new 2023 Nissan Z MSRP to start at $39,990
Nissan today announced the MSRP1 for the latest iteration of its “attainable dream car,” the 2023 Nissan Z – $39,990 for the Z Sport and $49,990 for the Z Performance. Both grades are scheduled to arrive at Nissan dealerships nationwide in Summer 2022....
May 16, 2022 00:01 ET
Envoy Gateway Makes Using Envoy Proxy Easier for Developers and Reverses Fragmentation
Members of the steering group for Envoy Gateway (EG), including Envoy creator Matt Klein and representatives from Ambassador Labs, Fidelity Investments, Tetrate, and VMware, Inc., today announced their joint commitment to the project, which launched today at KubeCon + CloudNativeCon, Europe 2022, under the auspices of the Cloud Native Computing Foundation® (CNCF®). Envoy Gateway is a new effort within the Envoy proxy open source project to simplify Envoy use in cloud-native application development....
May 16, 2022 00:00 ET
Axion BioSystems Welcomes Biotech Industry Leader Kevin Gould as New CEO
Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, announces that Kevin Gould has been appointed the company’s Chief Executive Officer, effective immediately. With more than 20 years of senior mana...
May 15, 2022 20:00 ET
HappyFresh Digitally Transforms Warehouse Capabilities With Blue Yonder
Consumer grocery shopping habits changed as a result of the COVID-19 pandemic with many opting for delivery. To meet the increased demand for its services, HappyFresh, an online grocery startup company, digitally transformed its warehouse operations with
May 15, 2022 18:14 ET
Otis College of Art and Design Announces Donation from the Spiegel Family Fund to Repay Student Loans for the Class of 2022
Otis College of Art and Design (“Otis College”), a nonprofit 501(c)3 institution that prepares students in the art and design capital of Los Angeles for a dynamic future in the creative economy, is honored to receive a significant donation from KORA Organics CEO Miranda Kerr and Snap Inc. CEO Evan Spiegel through the Spiegel Family Fund. The donation will allow for the repayment of the outstanding student debt of students in the graduating Class of 2022. This is the largest single gift in the history of Otis College and will reduce student debt for emerging artists and designers and their fami...
May 15, 2022 14:15 ET
ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in Three Posters at the ATS 2022 International Conference
ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery today presented new preclinical data from the company’s inhaled mRNA-based molecular therapy program for the treatment of primary ciliary dyskinesia (PCD) in three posters at the American Thoracic Society (ATS) 2022 International Confer...